Skip to content
value.today
Hinge Health, Inc. logo

Hinge Health, Inc.

Total raised
$852 M
7 rounds on record
Latest round
$400 M
Oct 2021
First round on record
Apr 2016
Today
Went public
See the company page

Hinge Health, Inc. is listed today as Hinge Health, Inc.: market value, financials and filings are on its company page.

Funding rounds

7 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Hinge Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2021$400 MNo. 7$250 million to $1 billion

Hinge Health, Inc.: Raise no. 7, Oct 2021

Investors in this round

2 investors had bought by the notice of Dec 28, 2023: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$400 M of $400 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Annison · Executive Officer
  • Daniel Perez · Executive Officer, Director
  • David Wood · Executive Officer
  • Gabriel Mecklenburg · Executive Officer, Director
  • James Budge · Executive Officer
  • Jeffrey Krauss · Executive Officer
  • Jim Pursley · Executive Officer
  • Lalith Vadlamannati · Executive Officer
  • Mario Queiroz · Executive Officer
  • Ben Blume · Director
  • Elliott Robinson · Director
  • Teddie Wardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Wood, Secretary. Source: SEC Form D, newest notice filed Dec 28, 2023. Read the notice at the SEC.

equitySEC
Mar 2021$10 MIssued in a merger or acquisition$2 to $10 million

Hinge Health, Inc.: Private sale, Mar 2021

Investors in this round

65 investors had bought by the notice of Apr 1, 2021: 65 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $11 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Annison · Executive Officer
  • David Wood · Executive Officer
  • Gabriel Mecklenburg · Executive Officer, Director
  • Jeffrey Krauss · Executive Officer
  • Jim Pursley · Executive Officer
  • Ron Will · Executive Officer
  • Ben Blume · Director
  • Daniel Perez · Director
  • Elliott Robinson · Director
  • Teddie Wardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Wood, Secretary. Source: SEC Form D, newest notice filed Apr 1, 2021. Read the notice at the SEC.

equitySEC
Dec 2020$309 MNo. 6$250 million to $1 billion

Hinge Health, Inc.: Raise no. 6, Dec 2020

Investors in this round

21 investors had bought by the notice of Dec 21, 2023: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$309 M of $310 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Annison · Executive Officer
  • Daniel Perez · Executive Officer, Director
  • David Wood · Executive Officer
  • Gabriel Mecklenburg · Executive Officer, Director
  • James Budge · Executive Officer
  • Jeffrey Krauss · Executive Officer
  • Jim Pursley · Executive Officer
  • Lalith Vadlamannati · Executive Officer
  • Mario Queiroz · Executive Officer
  • Ben Blume · Director
  • Elliott Robinson · Director
  • Teddie Wardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Wood, Secretary. Source: SEC Form D, newest notice filed Dec 21, 2023. Read the notice at the SEC.

equity, optionsSEC
Jan 2020$92 MNo. 5$50 to $250 million

Hinge Health, Inc.: Raise no. 5, Jan 2020

Investors in this round

13 investors had bought by the notice of Jul 1, 2020: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$92 M of $92 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Perez · Executive Officer, Director
  • Gabriel Mecklenburg · Executive Officer, Director
  • Ben Blume · Director
  • Steve Kraus · Director
  • Teddie Wardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Perez, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 1, 2020. Read the notice at the SEC.

equity, optionsSEC
May 2019$15 MNo. 4$10 to $50 million

Hinge Health, Inc.: Raise no. 4, May 2019

Investors in this round

7 investors had bought by the notice of Jun 6, 2019: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Perez · Executive Officer, Director
  • Gabriel Mecklenburg · Executive Officer, Director
  • Ben Blume · Director
  • Teddie Wardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Perez, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 6, 2019. Read the notice at the SEC.

debt, optionsSEC
Jul 2018$26 MNo. 3$10 to $50 million

Hinge Health, Inc.: Raise no. 3, Jul 2018

Investors in this round

7 investors had bought by the notice of Jul 1, 2020: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Perez · Executive Officer, Director
  • Gabriel Mecklenburg · Executive Officer, Director
  • Carolina Brochado · Director
  • Peter Segall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Perez, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 1, 2020. Read the notice at the SEC.

equity, optionsSEC
Jul 2017$10 MNo. 2$2 to $10 million

Hinge Health, Inc.: Raise no. 2, Jul 2017

Investors in this round

7 investors had bought by the notice of Jul 24, 2017: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Perez · Executive Officer, Director
  • Gabriel Mecklenburg · Executive Officer, Director
  • Carolina Brochado · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Incl. above are $2,210,788 of securities issued following conversion of securities in issue”

Signed by Daniel Perez, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 24, 2017. Read the notice at the SEC.

equity, optionsSEC
Apr 2016$1 MNo. 1Under $2 million

Hinge Health, Inc.: Raise no. 1, Apr 2016

Investors in this round

4 investors had bought by the notice of Jun 20, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 19 investors are named for Hinge Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Perez · Executive Officer, Director
  • Gabriel Mecklenburg · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Amount Sold above includes Promissory Note and SAFE converted.”

Signed by Daniel Perez, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 20, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Hinge Health, Inc., its revenue in fiscal 2025 came from these business segments: Reportable $587.86 million (100%).

    Annual report (SEC XBRL) · Dec 2025

  • Hinge Health, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2023).

    SEC Form D · Dec 2023

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Dec 2023

Products and services#

No products or services of Hinge Health, Inc. are on record.

Investors#

19 named in official filings. Open an investor to see everything it has backed.

Investors in Hinge Health, Inc.
InvestorKindAmountRoundRoleSource
11.2 Capital HH, LLCFund or asset managernot statednot statedHeld Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025)SEC Form 3
11.2 Capital I, L.P.Fund or asset managernot statednot statedHeld Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025)SEC Form 3
11.2 Capital I Partners, LLCFund or asset managernot statednot statedHeld Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025)SEC Form 3
11.2 Capital Ivy, LLCFund or asset managernot statednot statedHeld Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025)SEC Form 3
11.2 Capital Ivy Partners, LLCFund or asset managernot statednot statedHeld Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Atomico Advisors IV, Ltd.Fund or asset managernot statednot statedHeld Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Atomico IV (Guernsey), L.P.Fund or asset managernot statednot statedHeld Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Atomico IV, L.P.Fund or asset managernot statednot statedHeld Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Bessemer Venture Partners X Institutional L.P.Venture capitalnot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Bessemer Venture Partners X L.P.Venture capitalnot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Deer X & Co. L.P.Fund or asset managernot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Deer X & Co. Ltd.Companynot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Holdings Group, LLCFund or asset managernot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Associates X, L.P.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Associates X, Ltd.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Partners (Cayman) X, L.P.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Partners (Delaware) X, L.P.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Partners X (Co-Investors), L.P.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Insight Venture Partners X, L.P.Venture capitalnot statednot statedHeld Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 21 investors.

Largest shareholders today

Institutions holding Hinge Health, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Hinge Health, Inc.
NameRoleNamed in
Alexander AnnisonExecutive officerDec 2023
Daniel PerezExecutive officerDec 2023
David WoodExecutive officerDec 2023
Gabriel MecklenburgExecutive officerDec 2023
James BudgeExecutive officerDec 2023
Jeffrey KraussExecutive officerDec 2023
Jim PursleyExecutive officerDec 2023
Lalith VadlamannatiExecutive officerDec 2023
Mario QueirozExecutive officerDec 2023
Ron WillExecutive officerApr 2021
Ben BlumeDirectorDec 2023
Daniel PerezDirectorDec 2023
Elliott RobinsonDirectorDec 2023
Gabriel MecklenburgDirectorDec 2023
Teddie WardiDirectorDec 2023
Carolina BrochadoDirectorJul 2020
Peter SegallDirectorJul 2020
Steve KrausDirectorJul 2020

Went public since 2025. Its SEC number is that of a company listed on a stock exchange.